Literature DB >> 9195389

Review: alpha 1-antitrypsin deficiency associated liver disease.

D Qu1, J H Teckman, D H Perlmutter.   

Abstract

alpha 1-Antitrypsin (alpha 1-AT) deficiency is the most common genetic cause of liver disease in children and genetic disease for which children undergo liver transplantation. It also causes cirrhosis and hepatocellular carcinoma in adults. Studies by Sveger in Sweden have shown that only a subgroup of the population with homozygous PiZZ alpha 1-AT deficiency develop clinically significant liver injury. Other studies have shown that the mutant alpha 1-AT Z molecule undergoes polymerization in the endoplasmic reticulum and that a subpopulation of alpha 1-AT-deficient individuals may be susceptible to liver injury because they also have a trait that reduces the efficiency by which the mutant alpha 1-AT Z molecule is degraded in the endoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195389     DOI: 10.1111/j.1440-1746.1997.tb00451.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

Review 1.  Advances in alpha-1-antitrypsin deficiency liver disease.

Authors:  Jeffrey H Teckman; Ajay Jain
Journal:  Curr Gastroenterol Rep       Date:  2014-01

2.  Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease.

Authors:  Clara Antoury; Rocio Lopez; Nizar Zein; James K Stoller; Naim Alkhouri
Journal:  World J Hepatol       Date:  2015-06-08

3.  Single nucleotide polymorphism-mediated translational suppression of endoplasmic reticulum mannosidase I modifies the onset of end-stage liver disease in alpha1-antitrypsin deficiency.

Authors:  Shujuan Pan; Lu Huang; John McPherson; Donna Muzny; Farshid Rouhani; Mark Brantly; Richard Gibbs; Richard N Sifers
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.